Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL3 | Q96JM7 | 10/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 10/20 | 0.40 |
| ▸ | MBTD1 | Q05BQ5 | 3/20 | 0.38 |
| ▸ | MAPT | P10636 | 4/20 | 0.35 |
| ▸ | APP | P05067 | 2/20 | 0.35 |
| ▸ | SNCA | P37840 | 1/20 | 0.35 |
| ▸ | TP53BP1 | Q12888 | 2/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Stilbazium SCHEMBL6446924 | 0.84 | MAPT (0.46) | L3MBTL1MAPTAPPSNCAPTGS2 | |
| Stilbazium SCHEMBL710325 | 0.83 | MAPT (0.44) | L3MBTL1MAPTAPPSNCAPTGS2 | |
| Stilbazium SCHEMBL636481 | 0.83 | SNCA (0.47) | L3MBTL1MAPTAPPSNCAPTGS2 | |
| Stilbazium SCHEMBL636482 | 0.83 | SNCA (0.47) | L3MBTL1MAPTAPPSNCAPTGS2 | |
| Stilbazium SCHEMBL710326 | 0.83 | MAPT (0.44) | L3MBTL1MAPTAPPSNCAPTGS2 | |
| SCHEMBL10068871 | 0.75 | ACHE (0.54) | L3MBTL1MAPTAPP | |
| SCHEMBL14139607 | 0.75 | ACHE (0.54) | MAPT | |
| Stilbazium SCHEMBL710711 | 0.70 | ESR1 (0.43) | L3MBTL1MAPTPTGS2 | |
| Stilbazium SCHEMBL710710 | 0.70 | ESR1 (0.43) | L3MBTL1MAPTPTGS2 | |
| SCHEMBL14536918 | 0.70 | SNCA (0.54) | MAPTAPPSNCAPTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7820696-B2 | Compounds and methods for controlling fungi, bacteria and insects | MYCOSOL, INC. (US) | 2010-10-26 | — | — | US | disclosed |
| US-20070213299-A1 | COMPOUNDS AND METHODS FOR CONTROLLING FUNGI, BACTERIA AND INSECTS | MYCOSOL, INC. | 2007-09-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070213299-A1 | COMPOUNDS AND METHODS FOR CONTROLLING FUNGI, BACTERIA AND INSECTS | BLVRB, PNPO, PLPBP | L3MBTL3 451/4885L3MBTL1 663/4885MBTD1 2160/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.